CRL vs SOLV — Key Metrics

Metric CRL (CHARLES RIVER LABORATORIES INTERNATIONAL INC) SOLV (SOLVENTUM CORP)
Price333.2586.48
Market Cap15.97 Billion14.68 Billion
P/E (TTM)311.4597.17
P/B (Quarterly)4.8453.08
P/S (TTM)4.021.8
Net Profit Margin (TTM)1.01.9
Gross Margin (TTM)33.354.8
ROE (TTM)1.33.2
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

CHARLES RIVER LABORATORIES INTERNATIONAL INC
vs
 
SOLVENTUM CORP
 
CHARLES RIVER LABORATORIES INTERNATIONAL INC
vs
 
SOLVENTUM CORP
Performance Comparison
AI Model Recommendation
CRL · CHARLES RIVER LABORATORIES INTERNATIONAL INC

Greatly Underperform

-80
UnderperformOutperform
SOLV · SOLVENTUM CORP

Outperform

38
UnderperformOutperform
Recommendation Summary

Stock CRL is projected to greatly underperform the market, stock SOLV is projected to outperform the market. Upfront Recommendation: SOLV.

Financial Metrics
Prices delayed ~15 min
CRL Metrics SOLV
$333.25 Price $86.48
— Market Capitalization —
311.45 Price to Earnings Ratio 97.17
4.02 Price to Sales 1.8
39.96 Price to FCF Ratio 47.65
12.05 Price to Gross Profit 3.28
10.4 Price to Current Assets 3.98

CRL vs SOLV at a glance

Charles River Laboratories International INC (CRL) and Solventum Corp (SOLV) are both in the Healthcare sector. They are similar in size: $16.0 billion and $14.7 billion in market value.

On trailing-twelve-month figures, CRL trades at 311.4 times trailing earnings and SOLV at 97.2; net profit margins are 1.0% and 1.9%.

The Upfront Investment model currently rates CRL Greatly Underperform and SOLV Outperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.